by Maria Zannes | Jan 27, 2021 | Events
Chief Medical & Science Officer Vivienne Rebel, MD, PhD, will present her poster “Automated Flow Cytometry Test Distinguishes Cancer from Non-Cancer in Sputum with High Sensitivity and Specificity” on January 28th through January 31st, 2021, at the International...
by Maria Zannes | Jan 27, 2021 | Articles
JANUARY 19, 2021 Contributed Commentary by Maria Zannes When it comes to cancer, there are many tools for cancer diagnosis, from initial screenings to invasive biopsies. The one selected depends on a number of factors, not the least of which is how the patient...
by Maria Zannes | Nov 25, 2020 | Articles
NOVEMBER 23, 2020 By: Maria Zannes, HealthcareNOW Radio My father was 39 when he died of lung cancer, attributed to his twenty-year Lucky Strikes habit. The U.S. Surgeon General had yet to issue his first report on the health hazards of smoking in 1960 when my father...
by Maria Zannes | Nov 10, 2020 | Events, Press Releases
Nov. 10, 2020 (San Antonio, TX) bioAffinity Technologies, a privately held biotech company, today announced that its poster “Meso-tetra (4-carboxyphenyl) porphyrin (TCPP) is incorporated into cancer cells by the CD320 receptor and clathrin mediated endocytosis” will...
by Maria Zannes | Oct 22, 2020 | Events, Press Releases
OCTOBER 22, 2020 (San Antonio, TX) bioAffinity Technologies, a privately held biotech company, announced its poster “Automated Flow Cytometry Test Distinguishes Cancer from Non-Cancer in Sputum with High Sensitivity and Specificity” has been accepted for presentation...
